Bad news for top-selling anemia drug
17th Nov 2006, 00:02 GMT
A new medical study suggests that high doses of a best-selling drug used to treat anemia in dialysis and cancer patients may increase the risk of heart problems and death.
Latest news from Americas - International Herald Tribune:
- A 'new' Democrat with an old-fashioned flair
- Seoul balks at U.S. plan to enforce naval ban
- Foreign students resume influx at U.S. colleges
- Post-election Congress has a long to-do list
- California is ready to reap rewards of Democrats' victory
- Airbus crash issues linger in U.S.
- Hospitals aim to give faster care
- Hamas and Fatah back leader for new Palestinian government
- Brazil 'rubber soldiers' fight for recognition
- Republican losses are California's gain